Back to
APG Asset Management N.V.
CORT
Showing 0 of 13 quarters
Position history for
APG Asset Management N.V.'s holdings in Corcept Therapeutics Incorporated
No. APG Asset Management exited its CORT (Corcept Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 11,000 shares worth $323,433. APG Asset Management first reported CORT in Q2 2020 and held it in 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.